Teclistamab in Relapsed Refractory Multiple Myeloma Patients on Dialysis: A French Experience

被引：4
|
作者：
Lachenal, Florence [1 ]
Lebreton, Pierre [2 ]
Bouillie, Sylvie [3 ]
Matteo, Gian [4 ]
Aftisse, Hassina [5 ]
Pascal, Laurent [6 ]
Montes, Lydia [7 ]
Macro, Margaret [8 ]
Vignon, Marguerite [9 ]
Harel, Stephanie [10 ]
Fernandez, Mariana [11 ]
Louni, Chanaz [12 ]
Huart, Antoine [13 ]
Perrot, Aurore [14 ]
机构：
[1] GHND Grp Hosp Nord Dauphine, Bourgoin Jallieu, France
[2] Grp Hosp Havre, Le Havre, France
[3] Janssen, Issy Les Moulineaux, France
[4] CH Chambery, Dept Hematol, Chambery, France
[5] Ctr Hosp St Quentin, St Quentin en Yvelines, France
[6] Hop St Vincent De Paul, Lille, France
[7] Ctr Hosp Univ Amiens Picardie, Serv Hematol, Amiens, France
[8] Hop Cote Nacre, Caen, France
[9] Hop Cochin, AP HP, Hematol Clin, Paris, France
[10] St Louis Hosp, Paris, France
[11] Janssen Cilag Spain, Madrid, Spain
[12] IFM, Paris, France
[13] CHU Toulouse Rangueil, Dept Nephrol & Transplantat, Toulouse, France
[14] Univ Toulouse, CHU Toulouse, IUCT O, UPS,Serv Hematol, Toulouse, France
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180660
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Teclistamab in Relapsed or Refractory Multiple Myeloma
    Hindie, Elif
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (18): : 1721 - 1723
  • [2] Teclistamab in Relapsed or Refractory Multiple Myeloma
    Moreau, Philippe
    Garfall, Alfred L.
    van de Donk, Niels W. C. J.
    Nahi, Hareth
    San-Miguel, Jesus F.
    Oriol, Albert
    Nooka, Ajay K.
    Martin, Thomas
    Rosinol, Laura
    Chari, Ajai
    Karlin, Lionel
    Benboubker, Lotfi
    Mateos, Maria-Victoria
    Bahlis, Nizar
    Popat, Rakesh
    Besemer, Britta
    Martinez-Lopez, Joaquin
    Sidana, Surbhi
    Delforge, Michel
    Pei, Lixia
    Trancucci, Danielle
    Verona, Raluca
    Girgis, Suzette
    Lin, Shun X. W.
    Olyslager, Yunsi
    Jaffe, Mindy
    Uhlar, Clarissa
    Stephenson, Tara
    Van Rampelbergh, Rian
    Banerjee, Arnob
    Goldberg, Jenna D.
    Kobos, Rachel
    Krishnan, Amrita
    Usmani, Saad Z.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (06): : 495 - 505
  • [3] Ambulatory teclistamab administration in patients with relapsed/refractory multiple myeloma
    Tabbara, Nadeem
    Singel, Michael
    Allen, Natalie
    Mooney, Kathy
    Shedeck, Audra
    Zukas, Amber
    Campion, Kate
    Sollenberger, Callan
    Gocke, Christian Burris
    Ali, Syed Abbas
    Huff, Carol Ann
    Imus, Philip H.
    Waheed, Sarah
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] French Monocentric Experience of Outpatient Step-up Dosing of Teclistamab in Relapsed Refractory Multiple Myeloma
    Hebraud, Benjamin
    Granell, Miguel
    Lapierre, Leopoldine
    Mouchel, Pierre Luc
    Beziat, Guillaume
    Sicard, Nina
    Bonneau, Maeva
    Higue, Jules
    Sougy, Florence
    Perriat, Sophie
    Morel, Charlotte
    Bories, Pierre
    Corre, Jill
    Loiseau, Herve Avet
    Recher, Christian
    Perrot, Aurore
    BLOOD, 2023, 142
  • [5] Safety and Efficacy of Teclistamab in Patients with Relapsed/ Refractory Multiple Myeloma: A Real-World Experience
    Dima, Danai
    Davis, James A.
    Ahmed, Nausheen
    Jia, Xuefei
    Sannareddy, Aishwarya
    Shaikh, Hira
    Shune, Leyla
    Kaur, Gurbakhash
    Khouri, Jack
    Afrough, Aimaz
    Strouse, Christopher
    Lochner, Jonathan
    Mahmoudjafari, Zahra
    Raza, Shahzad
    Valent, Jason
    Anderson Jr, Larry D.
    Anwer, Faiz
    Abdallah, Al-Ola
    Hashmi, Hamza
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 308.e1 - 308.e13
  • [6] Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
    James A. Davis
    Jordan Snyder
    Mikhaila Rice
    Donald C. Moore
    Christopher Cahoon
    Kelley Julian
    Charlotte B. Wagner
    Katelynn Granger
    Kimberly M. Green
    Shebli Atrash
    Hailey Hill
    Jessica McElwee
    Grace Elsey
    Jack Khouri
    Joslyn Rudoni
    Zahra Mahmoudjafari
    Victoria R. Nachar
    Blood Cancer Journal, 15 (1)
  • [7] Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program
    Uttervall, Katarina
    Nahi, Hareth
    Kashif, Muhammad
    Lemonakis, Konstantinos
    Rosengren, Sara
    Brolin, Janaki
    Lund, Johan
    Hansson, Markus
    BLOOD, 2022, 140 : 12605 - 12606
  • [8] Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma
    Girgis, Suzette
    Lin, Shun Xin Wang
    Pillarisetti, Kodandaram
    Verona, Raluca
    Vieyra, Diego
    Casneuf, Tineke
    Fink, Damien
    Miao, Xin
    Chen, Yang
    Stephenson, Tara
    Banerjee, Arnob
    Hilder, Brandi W.
    Russell, Jeffery
    Infante, Jeffrey
    Elsayed, Yusri
    Smit, Jennifer
    Goldberg, Jenna D.
    BLOOD ADVANCES, 2023, 7 (04) : 644 - 648
  • [9] Real World Evaluation of Teclistamab: A Focus on Infections in Patients With Relapsed Refractory Multiple Myeloma (RRMM)
    Asoori, Sireesha
    Martin, Thomas
    Wolf, Jeffrey
    Chung, Alfred
    Arora, Shagun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S536 - S537
  • [10] Initial report of a single institution experience with teclistamab for relapsed or refractory multiple myeloma including prior BCMA
    Faiman, Beth
    Dima, Danai
    Duco, Marissa
    Rice, Mikhaila
    Rudoni, Joslyn
    Anwer, Faiz
    Khouri, Jack
    Mazzoni, Sandra
    Raza, Shahzad
    Samaras, Christy
    Williams, Louis
    Valent, Jason
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S177 - S177
12345